Saibriga (Brigatinib) 90mg*30's | Generic ALK Inhibitor Laos | GLT

REQUEST A QUOTE

For individuals and institutions — pricing, availability, and product documents (COA) provided within 24 hours.
Direct line: [email protected] · +86 15234153837

分享
Product description

Generic Information: Saibriga (Laos)

Saibriga is a Lao-manufactured generic of brigatinib, produced by BioSpring.LTD. It is supplied as 90 mg tablets in a 30-tablet pack, matching the lead-in and standard 90 mg maintenance dose of the brigatinib regimen. As a second-generation ALK inhibitor generic, Saibriga delivers the same active ingredient as the originator at a lower, out-of-pocket-friendly price.

What Is Saibriga Used For?

Saibriga is used to treat anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer, including in patients whose disease has progressed on or who cannot tolerate crizotinib. It is an oral, once-daily monotherapy that is easy to take at home, and it is prescribed only after a genetic test confirms the ALK rearrangement.

How Does Saibriga (Brigatinib) Work?

The brigatinib in Saibriga is a next-generation ALK tyrosine kinase inhibitor that also inhibits ROS1, IGF-1R, and FLT-3. It blocks the growth signals that drive ALK-positive cancer cells and crosses the blood-brain barrier, making it effective against brain metastases. The generic Saibriga carries the same active ingredient and mechanism as the originator at a lower cost.

Indications

Saibriga is indicated for adults with ALK-positive, locally advanced or metastatic NSCLC. A confirmed ALK rearrangement is required before prescribing. It is not appropriate for ALK-negative disease and is not indicated for small-cell lung cancer.

Dosage

The recommended regimen is 90 mg once daily for 7 days, then 180 mg once daily if tolerated. The 90 mg tablets in this listing support the lead-in phase and the 90 mg maintenance dose. Take the tablet with or without food and swallow it whole. If a dose is missed or vomited, do not take an extra tablet — continue with the next scheduled dose.

Side Effects

Common adverse reactions include diarrhea, rash, cough, hypertension, fatigue, nausea, muscle pain, and headache. Blood pressure should be monitored during treatment, and diarrhea is generally manageable with supportive care. Interstitial lung disease is rare but serious and requires permanent discontinuation if confirmed.

Storage

Store Saibriga below 30°C in a dry place, in its original container, and out of the reach of children. No refrigeration is required.

Why Choose the GLT?

For uninsured or under-insured patients, a Lao generic such as Saibriga offers a substantial saving over the originator brand, whose Western list price is very high. GLT sources from established manufacturers and provides the documentation required for safe international shipping, helping patients maintain affordable and continuous therapy.

How to Order

To order Saibriga through GLT, contact us on WhatsApp at +86 15234153837 or email [email protected]. Provide the strength, quantity, and destination country, and we will confirm availability, sourcing origin, and delivery terms. We support both institutional purchasers and individual patients.

FAQ

Is Saibriga a generic of Alunbrig? Yes. Saibriga is a Lao-manufactured generic of brigatinib, the active ingredient in Alunbrig, produced by BioSpring.LTD.

What strength does Saibriga come in? This listing is the 90 mg strength in a 30-tablet box, matching the lead-in and standard 90 mg maintenance dose.

Can I buy generic brigatinib online? Generic brigatinib can be purchased through international suppliers such as GLT. Always confirm the supplier's legitimacy and request proper documentation before ordering.

Related Oncology Products

Mounjaro KwikPen(替尔泊肽)10–60mg/2.4mL 多剂量注射笔 | 礼来(美国)| GLT

Mounjaro KwikPen——礼来单患者多剂量注射笔,六种美国规格(10–60mg/2.4mL,各 4 剂)用于 2 型糖尿病。

奥氟格列隆/奥格列龙(OriYo)0.8–17.2mg 片剂 | 孟加拉仿制药 口服 GLP-1 | GLT

孟加拉国民制药(National Drug Co.)仿制奥氟格列隆,6 剂量递增用于体重管理

Tixepa(替尔泊肽)20mg/2mL 和 30mg/2mL 多剂量注射笔 | Drug International | GLT

Tixepa——Drug International Limited (DIL) 替尔泊肽多剂量注射笔,两种官方规格(Tixepa-5=20mg/2mL,Tixepa-7.5=30mg/2mL)用于 2 型糖尿病和肥胖。

Palutini(巴瑞替尼)4mg | 仿制 JAK1/JAK2 抑制剂 | Trans Continental Life Science & Pharmaceuticals (TLPH) | GLT

由 Trans Continental Life Science & Pharmaceuticals (TLPH)(老挝)生产的仿制巴瑞替尼(JAK1/JAK2 抑制剂)——用于类风湿关节炎、特应性皮炎和斑秃,是 Olumiant 的平价替代品。

Barinat(巴瑞替尼)4mg | 仿制 JAK1/JAK2 抑制剂 | Natco Pharma Limited | GLT

由 Natco Pharma Limited(印度)生产的仿制巴瑞替尼(JAK1/JAK2 抑制剂)——用于类风湿关节炎、特应性皮炎和斑秃,是 Olumiant 的平价替代品。

Olumiant(巴瑞替尼)2mg/4mg 片 | JAK1/JAK2 抑制剂 | 礼来(美国)| GLT

礼来公司的选择性 JAK1/JAK2 抑制剂,用于类风湿关节炎、特应性皮炎和重度斑秃。

Zepbound(替尔泊肽)2.5–15mg/0.5mL 单剂量注射笔 | 礼来(美国)| GLT

Zepbound——礼来替尔泊肽单剂量注射笔,六种美国规格(2.5–15mg/0.5mL),用于慢性体重管理和阻塞性睡眠呼吸暂停。